Stem Cell Transplantation

Critical T-Cell Threshold for Graft-vs.-Host-Disease Prevention

Published in Blood Weekly, November 1st, 1999

Researchers from Germany demonstrated a residual T-cell content that is safe for the prevention of graft-versus-host disease after stem cell transplantation in some pediatric patients.

S.M. Muller and colleagues at Germany's University Ulm, Children's Hospital, said the aim of their study was to reduce the rate of graft failure after HLA non-identical stem cell transplantation by using G-CSF mobilized CD34⁺ peripheral blood progenitor cells (PBPC), either in combination with bone marrow or as single grafts.

Muller et al. published their study in Bone Marrow Transplantation ("Definition of a Critical T-Cell Threshold for Prevention of GVHD...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1999-11-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry